Cargando…

Drug-eluting stent for acute Blalock-Taussig shunt thrombosis in a child—case report

BACKGROUND: Blalock-Taussig shunt (BTS) continues to have a relatively high operative and short-term mortality, even in the current era. We report the use of drug-eluting stent in a child with acute shunt thrombosis, which has not been reported in the literature to date. CASE PRESENTATION: A 7-month...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopalakrishnan, Arun, Sasidharan, Bijulal, Menon, Sabarinath, Krishnamoorthy, Kavassery Mahadevan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447713/
https://www.ncbi.nlm.nih.gov/pubmed/32844250
http://dx.doi.org/10.1186/s43044-020-00084-y
Descripción
Sumario:BACKGROUND: Blalock-Taussig shunt (BTS) continues to have a relatively high operative and short-term mortality, even in the current era. We report the use of drug-eluting stent in a child with acute shunt thrombosis, which has not been reported in the literature to date. CASE PRESENTATION: A 7-month-old boy with double outlet right ventricle, severe pulmonary stenosis, and normally related great arteries underwent BTS placement for cyanotic spells. Ten days after discharge, he presented with shock due to a blocked BTS. He underwent emergency percutaneous revascularization of the shunt with a drug-eluting stent and is doing well at 9 months’ follow-up on dual antiplatelet therapy. CONCLUSIONS: Drug-eluting stents may be used in children with BTS thrombosis.